Top CDC leader to step down

The principal deputy director of the Centers for Disease Control and Prevention is stepping down from her role, marking the second high-profile departure from the agency in the span of a month.

Anne Schuchat, MD, the CDC’s No. 2 in command, will vacate her role this summer, after serving as a scientist with the CDC for more than 30 years. She has served as principal deputy director since 2015. The news was first reported by Politico and confirmed by the CDC.

“I have enormous gratitude for Dr. Schuchat’s leadership and contributions over three decades, and during this very challenging period for our country,” CDC Director Rochelle Walensky, MD, said in a statement. “I will remain forever grateful that our paths crossed, even for just a short while.”

Longtime senior scientist Nancy Messonnier announced her departure earlier in May. Messonnier led the CDC’s response to the COVID-19 pandemic, STAT News reported.

The departures come at a fraught time for the agency, which has faced criticism and praise for its handling of the COVID-19 pandemic across the Trump and Biden administrations. 

In recent months, Schuchat clashed with Walensky, a source told Politico. Prior to Walensky’s appointment by the Biden administration, Schuchat was once in the running for the top job as director. 

She was also involved in the CDC’s decision to temporarily pause the Johnson & Johnson COVID-19 vaccine in April. That decision was sharply criticized for causing confusion over vaccine safety and efficacy after the agency ultimately allowed the vaccine to continue to be distributed.

According to Politico, Schuchat also was involved in internal battles between CDC scientists and the Trump administration, after the Trump administration attempted to interfere with scientific reports, including one she authored.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.